VP shunt infections: Difference between revisions
| Line 24: | Line 24: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Neuro]] | |||
[[Category:ID]] | |||
Revision as of 04:35, 6 June 2015
Background
Causative agents
Clinical Features
Differential Diagnosis
Diagnosis
Management
Pediatric
- Empiric therapy: Vancomycin AND Cefotaxime 200 mg/kg/day IV div Q6 OR ceftriaxone 100 mg/kg/day IV div Q12-24
- Always involved neurosurgery in management
- Tailor antimicrobial therapy to culture results